NEW YORK, NY / ACCESS Newswire / November 13, 2025 / – SueWallSt: Class Action Filed Against CarMax, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between June 20, 2025 and September 24, 2025. If you suffered […]

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / – SueWallSt: Class Action Filed Against Synopsys, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between December 4, 2024 and September 9, 2025. If you suffered

What if we could deliver advanced hospital-level care to every rural county in America? That's the question thatPARADIGMset out to answer. https://mma.prnewswire.com/media/1980786/ECRI_Logo_2025.jpg The Platform Accelerating Rural Access to Distributed and InteGrated Medical Care (PARADIGM) program aims to improve rural health by creating a scalable vehicle platform that can provide advanced medical services outside of a

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / – SueWallSt: Class Action Filed Against Avantor, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between March 5, 2024 and October 28, 2025. If you suffered

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / – SueWallSt: Class Action Filed Against DexCom, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between January 8, 2024 and September 17, 2025. If you suffered

Words have power. A heated comment, an angry post on social media, or a moment of frustration can sometimes spiral into something far more serious, resulting in criminal charges. But when does free speech cross the line from protected expression to a criminal threat? Our criminal threat defense attorneys in Wichita, Kansas, at theMcConnell Law

Myeloma Canada welcomes the Canadian Drug Agency's (CDA) two positive recommendationsfor the reimbursement of Blenrep® (belantamab mafodotin) – a critical new treatment option for Canadians living with relapsed or refractory multiple myeloma (RRMM). Approved by Health Canada in July 2025, Blenrep® is the first and only anti-BCMA (B-cell maturation antigen) antibody-drug conjugate (ADC) for multiple

Loosid, the leading clean and sober lifestyle brand, today announced that it has secured a second round of funding from Amazon Web Services (AWS) to support the launch of its Sobriety and Addiction Mentor (SAM™ AI) for enterprise organizations. To secure this funding, Loosid partnered with Innovative Solutions, a Premier Tier AWS Partner with Generative

(Other OTC:INVU),(OTC US:INVU),(OTC US:INVUP),(Other OTC:INVUP), Haverford, PA, Nov. 13, 2025 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU), a diversified financial technology services company operating across multiple business units that feature the sale of financial education products and services through a global network of independent distributors, the manufacture and sale of consumer health, wellness and nutrition

Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2025 GlobeNewswire November 13, 2025 Haverford, PA, Nov. 13, 2025 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU), a diversified financial technology services company operating across multiple business units that feature the sale of financial education products and